As per the data of Worldometer, as of July 1st, 2021, in India the number of cases has been increasing and reached to 30,411,634 cases with 399,475 deaths. Thus, these many advances in sequential compression devices are likely to act as a future trend in the market.Ĭountries in APAC are facing challenges due to increasing incidences of COVID-19.
has announced preliminary data for Lympha Press PCD-51 for the treatment of chronic venous stasis ulcers.
#Normatec pcd pneumatic compression device plus
Similarly, in December 2020, Tactile Medical has received 510(k) clearance for two new indications for the Flexitouch Plus system: phlebolymphedema and lipedema. Also, the NormaTec recovery system designed by Normatec in 2016 uses the latest pulse technology for dynamic compression therapy.Moreover, Profore, a compression system developed by Smith & Nephew in 2015 comprises an extra padding layer to protect vulnerable areas such as the Achilles tendon and pretibial crest. developed ACCEL technology, helping integrate pneumatic compression and cold therapy. For instance, in 2016, Cool Systems, Inc. Market players are investing in R&D to develop advanced technologies and gain more revenue share. The market players adopt strategies such as new product launches, regional expansion, and technological advancements to increase their market share. The home sequential compression devices market is characterized by the presence of various small and big companies. Sequential compression devices witness significant advancement is the major factor driving the growth of the APAC home sequential compression devices market.
The home sequential compression devices market in APAC is expected to grow from US$ 211.60 million in 2021 to US$ 347.75 million by 2028 it is estimated to grow at a CAGR of 7.4% from 2021 to 2028.Īustralia, China, India, Japan, and South Korea are major economies in APAC. Minimally Invasive/Non-Invasive Surgery.Aerospace & Defense Systems & Technologies.
0 kommentar(er)
